See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600132_2016_Bellerophon_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | NetIncome node detected by IncomeLoss name heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001600132, Bellerophon Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 29,452,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,799,000 |
| 3 | remainder_Assets | 7,158,000 |
| 4 | LiabilitiesCurrent | 8,073,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,870,000 |
| 9 | ResearchAndDevelopmentExpense | 33,365,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,667,000 |
| 12 | remainder_NetIncome | 109,000 |
| 13 | remainder_ComprehensiveNetIncome | -19,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 38,409,000 |
| 1 | Liabilities | 8,073,000 |
| 2 | Expenses | 48,235,000 |
| 3 | Revenues | 1,667,000 |
| 4 | StockholdersEquity | 30,336,000 |
| 5 | NetIncome | -46,459,000 |
| 6 | ComprehensiveNetIncome | -46,468,500 |
| 7 | BaseVar | 48,256,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.846 |
| 9 | EconomicCapitalRatio | 2.18 |
Edgar->Model Mapping
Feature Distribution
